Delivery Order SPE2DB24D2100-SPE2DB24FBBCM
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,954.08 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a performance period through May 1, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,144.38 firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is for the supply of 4564313232 - Cyclosporine 0.05% eye emulsion with an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,072.71 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 4564366186 - CYCLOSPORINE 0.05% EYE EMULS 30S. This contract has an ultimate completion date of April 24, 2024 and was awarded on April 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical supplier to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,042.35 firm fixed price delivery order by the Defense Logistics Agency (DLA) for CYCLOSPORINE 0.05% EYE EMULS 30S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp as the sole prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This federal contract award was issued by the Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp's Corporate Office Division. The $29,251.15 Firm Fixed Price delivery order is for the supply of 4558352040 - Cyclosporine 0.05% Eye Emulsion in 30s. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $2,092.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Cyclosporine 0.05% eye emulsion. This award has a completion date of March 6, 2024 and is not set aside. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,816.49 delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the Defense Logistics Agency Troop Support Medical, running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The $10,634.42 firm fixed price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical pharmaceutical product. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $12,801.03 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Cyclosporine 0.05% eye emulsion. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,299.90 firm-fixed-price delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULSION 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBBCMDelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a $14,529.29 Firm Fixed Price Delivery Order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 4564389608 - CYCLOSPORINE 0.05% EYE EMULS 60S, with a completion date of April 25, 2024. The award is not associated with any set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to federal agencies, including the Department of Defense (DoD) and Department of Veterans Affairs (VA), under several Indefinite Delivery Contracts (IDCs) with these agencies. This specific award falls under Amerisourcebergen's $999,999,999.00 IDC with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical and medical products to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 4/24/24 |